Small Pharma Stock Cash And Equivalents
Small Pharma fundamentals help investors to digest information that contributes to Small Pharma's financial success or failures. It also enables traders to predict the movement of Small OTC Stock. The fundamental analysis module provides a way to measure Small Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Small Pharma otc stock.
Small |
Small Pharma OTC Stock Cash And Equivalents Analysis
Small Pharma's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Small Pharma Cash And Equivalents | 27.15 M |
Most of Small Pharma's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Small Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Small Pharma has 27.15 M in Cash And Equivalents. This is 96.69% lower than that of the Healthcare sector and 93.93% lower than that of the Biotechnology industry. The cash and equivalents for all United States stocks is 99.0% higher than that of the company.
Small Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Small Pharma's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Small Pharma could also be used in its relative valuation, which is a method of valuing Small Pharma by comparing valuation metrics of similar companies.Small Pharma is currently under evaluation in cash and equivalents category among its peers.
Small Fundamentals
| Return On Equity | -0.78 | |||
| Return On Asset | -0.41 | |||
| Current Valuation | 24.67 M | |||
| Shares Outstanding | 321.56 M | |||
| Shares Owned By Insiders | 31.08 % | |||
| Shares Owned By Institutions | 3.00 % | |||
| Price To Book | 1.15 X | |||
| Price To Sales | 69,846 X | |||
| Gross Profit | 45 K | |||
| EBITDA | (22.47 M) | |||
| Net Income | (22.27 M) | |||
| Cash And Equivalents | 27.15 M | |||
| Cash Per Share | 0.08 X | |||
| Current Ratio | 6.62 X | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (16.23 M) | |||
| Earnings Per Share | (0.06) X | |||
| Number Of Employees | 10 | |||
| Market Capitalization | 27.33 M | |||
| Total Asset | 45.57 M | |||
| Net Asset | 45.57 M |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Small OTC Stock
If you are still planning to invest in Small Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Small Pharma's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |